Everest Organics Ltd vs Sai Parenterals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Everest Organics Ltd is ₹ 263 as of 05 May 15:30 . The P/E Ratio of Everest Organics Ltd is 0 as of March 2023 .The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 . The Market Cap of Everest Organics Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 . The revenue of Everest Organics Ltd for the Dec '25 is ₹ 42.84 crore as compare to the Sep '25 revenue of ₹ 51.29 crore. This represent the decline of -16.47% The revenue of Sai Parenterals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Everest Organics Ltd for the Dec '25 is ₹ 3.79 crore as compare to the Sep '25 ebitda of ₹ 5.42 crore. This represent the decline of -30.07% The ebitda of Sai Parenterals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Everest Organics Ltd changed from ₹ -6.09 crore to ₹ 0.36 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Sai Parenterals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Everest Organics Ltd changed from 8.75 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993.
It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
The Company commenced its commercial operations in the year 1993.
It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

FAQs for the comparison of Everest Organics Ltd and Sai Parenterals Ltd

Which company has a larger market capitalization, Everest Organics Ltd or Sai Parenterals Ltd?

Market cap of Everest Organics Ltd is 255 Cr while Market cap of Sai Parenterals Ltd is 2,161 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and Sai Parenterals Ltd?

The stock performance of Everest Organics Ltd and Sai Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and Sai Parenterals Ltd?

As of May 5, 2026, the Everest Organics Ltd stock price is INR ₹263.0. On the other hand, Sai Parenterals Ltd stock price is INR ₹489.35.

How do dividend payouts of Everest Organics Ltd and Sai Parenterals Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and Sai Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.